These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9854570)

  • 41. [Hürthle cell carcinoma of the thyroid. A 41 years experience].
    Sanz J; Cerpa F; Domínguez M; Franco C; Jadresic A; Pérez G; Phillipi V
    Rev Med Chil; 1999 Jul; 127(7):821-6. PubMed ID: 10668290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term survival rates in young patients with thyroid carcinoma.
    Kowalski LP; Gonçalves Filho J; Pinto CA; Carvalho AL; de Camargo B
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):746-9. PubMed ID: 12874076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hurthle cell neoplasms of the thyroid.
    Dahl LD; Myssiorek D; Heller KS
    Laryngoscope; 2002 Dec; 112(12):2178-80. PubMed ID: 12461336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Follicular variant of papillary thyroid carcinoma: a long-term follow-up.
    Passler C; Prager G; Scheuba C; Niederle BE; Kaserer K; Zettinig G; Niederle B
    Arch Surg; 2003 Dec; 138(12):1362-6. PubMed ID: 14662540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
    Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
    Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic factors in patients with differentiated thyroid carcinoma.
    Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P
    Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Follicular and Hurthle cell carcinomas of the thyroid: a comparative study.
    Evans HL; Vassilopoulou-Sellin R
    Am J Surg Pathol; 1998 Dec; 22(12):1512-20. PubMed ID: 9850177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Follicular carcinoma.
    Franssila KO; Ackerman LV; Brown CL; Hedinger CE
    Semin Diagn Pathol; 1985 May; 2(2):101-22. PubMed ID: 3843689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    Am Surg; 2007 May; 73(5):484-91. PubMed ID: 17521005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
    Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.
    Erickson LA; Jin L; Goellner JR; Lohse C; Pankratz VS; Zukerberg LR; Thompson GB; van Heerden JA; Grant CS; Lloyd RV
    Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radioactive iodine offers survival improvement in patients with follicular carcinoma of the thyroid.
    Podnos YD; Smith D; Wagman LD; Ellenhorn JD
    Surgery; 2005 Dec; 138(6):1072-6; discussion 1076-7. PubMed ID: 16360393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic factors in follicular carcinoma of the thyroid.
    Jorda M; Gonzalez-Campora R; Mora J; Herrero-Zapatero A; Otal C; Galera H
    Arch Pathol Lab Med; 1993 Jun; 117(6):631-5. PubMed ID: 8503737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Further evidence of the validity of risk group definition in differentiated thyroid carcinoma.
    Cady B; Rossi R; Silverman M; Wool M
    Surgery; 1985 Dec; 98(6):1171-8. PubMed ID: 4071392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Micromedullary thyroid cancer: how micro is truly micro?
    Pillarisetty VG; Katz SC; Ghossein RA; Tuttle RM; Shaha AR
    Ann Surg Oncol; 2009 Oct; 16(10):2875-81. PubMed ID: 19568813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hurthle cell neoplasm of the thyroid gland.
    Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
    ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
    Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S
    World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Small thyroid carcinomas: biological characteristics, diagnosis and therapy].
    Gemsenjäger E; Schweizer I
    Schweiz Med Wochenschr; 1999 May; 129(18):681-90. PubMed ID: 10407941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Follicular thyroid carcinoma: prognostic factors and the role of radioiodine.
    Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Yuen KT; Law CC; Lau WH
    Cancer; 2002 Aug; 95(3):488-98. PubMed ID: 12209740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.